您的位置: 首页 > 农业专利 > 详情页

Heteroaromatic compounds as bruton’s tyrosine kinase (btk) inhibitors
专利权人:
Boehringer Ingelheim International GmbH
发明人:
Bentzien Joerg Martin,Berry Angela Kay,Bosanac Todd,Burke Michael Jason,Disalvo Darren Todd,Horan Joshua Courtney,Liang Shuang,Mao Can,Mao Wang,Shen Yue,Soleymanzadeh Fariba,Zindell Renee M.
申请号:
NZ70360713
公开号:
NZ703607A
申请日:
2013.08.08
申请国别(地区):
NZ
年份:
2018
代理人:
摘要:
The present invention encompasses compounds of the formula (I) wherein the groups A, Cy, XI and Y are defined herein, which are suitable for the treatment of a disease chosen from rheumatoid arthritis, systemic lupus erythromatosis, scleroderma, asthma, allergic rhinitis, allergic eczema, B cell lymphoma, multiple sclerosis, juvenile rheumatoid arthritis, juvenile idiopathic arthritis, inflammatory bowel disease, graft versus host disease, psoriatic arthritis, ankylosing spondylitis and uveitis.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充